- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13:26 | Solid Biosciences' SGT-212 gains FDA rare paediatric disease status | ||
| 11:26 | Lotus submits NDA for VIZZ in South Korea to treat presbyopia | ||
| Mo | Eisai seeks PMDA approval for subcutaneous Leqembi in Japan | ||
| Mo | US FDA approves Lupin's Armlupeg injection | ||
| Fr | IASO Bio gains Hong Kong approval for Fucaso application | ||
| Fr | MHRA approves Roche Products' inavolisib for breast cancer | ||
| Do | BeOne's sonrotoclax gains priority FDA review for mantle cell lymphoma | ||
| Do | Corstasis Therapeutics partners CVL for Enbumyst integration | ||
| Mi | UNICEF and Gavi to widen affordable malaria vaccine access | ||
| Mi | FDA grants accelerated approval for Otsuka's IgAN therapy | ||
| 25.11. | Made Scientific and Cellergy partner to advance CLG-001 | ||
| 25.11. | Novartis secures approval from FDA for Itvisma to treat SMA | ||
| 24.11. | AstraZeneca to expand biomanufacturing in Maryland, US | ||
| 24.11. | Vaximm and BCME link on oral cancer immunotherapy platform | ||
| 21.11. | Aspen closes $115m in Series C to advance Parkinson's cell therapy | ||
| 21.11. | Alvotech and Advanz announce EC approval for Gobivaz biosimilar | ||
| 20.11. | Pfizer and Tris agree with Texas over ADHD drug allegations | ||
| 20.11. | EC authorises Roche's Lunsumio SC for follicular lymphoma | ||
| 19.11. | USPTO grants patent to Genprex's Reqorsa gene therapy | ||
| 19.11. | Insmed receives EC approval for Brinsupri to treat NCFB | ||
| 18.11. | Johnson & Johnson to acquire Halda Therapeutics for $3.05bn | ||
| 17.11. | Sofinnova closes €650m healthcare fund for early-stage ventures | ||
| 14.11. | Eisai and Biogen report Leqembi's MHRA approval for Alzheimer's | ||
| 13.11. | BostonGene and Kyoto University link on oesophageal cancer drug | ||
| 12.11. | March Bio's MB-105 gains FDA RMAT for CD5+ T-cell lymphoma |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .